At the upcoming 18th edition the European Multidisciplinary Congress on Urological Cancers (EMUC26), which will take place from 5 to 8 November 2026, leading experts in genito-urological oncology, pathology, radiation oncology, radiology, nuclear medicine, and urology will examine the current practices, identify the best therapies, and review emerging innovations in genitourinary (GU) cancers treatment and management. At EMUC25 in Prague last month, editorial board members of the UROONCO Educational Platform recorded a series of in‑depth... What are the goals for neoadjuvant chemotherapy (NAC) in renal cell carcinoma (RCC)? Prof. Jens Bedke (DE) provided important... Below you can review some of the key topics covered at the EMUC25 Congress today. We share webcasts, session...Dear friends and colleagues,
Why you should attend EMUC26
News and reports
Expert interviews from EMUC25
Neoadjuvant treatment strategies in 2025
Highlights from Day 3
